热门资讯> 正文

希克玛制药在收购猜测中上涨

2026-02-05 00:47

HIKMA PHARMACEUTICALS(HKMPY) 0
Viatris, Inc.(VTRS) 0

Hikma Pharmaceuticals (HKMPY) may have attracted takeover speculation. Shares of Hikma rose as much as 8.8% in London trading.
The identity of the company interested in Hikma (HKMPY) is unclear, according to traders, who cited a Betaville "uncooked" alert that was circulating on Wednesday.
Past reports have speculated that Viatris (VTRS), Amgen (AMGN) and Novartis (NVS) may have looked at buying some or all of Hikma (HKMPY)

More on Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC (HKMPY) Shareholder/Analyst Call Transcript
Seeking Alpha’s Quant Rating on Hikma Pharmaceuticals PLC
Historical earnings data for Hikma Pharmaceuticals PLC
Dividend scorecard for Hikma Pharmaceuticals PLC
Financial information for Hikma Pharmaceuticals PLC

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。